Purchase Order 75D30118P01938
Award Date
8/1/18
Potential Completion Date
7/31/19
Potential Value
$150K
Federal Agency
CDC Pittsburgh
Awardee
Crosslife Technologies Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract in the amount of $299,974 to Crosslife Technologies Inc., a self-certified small disadvantaged business, for a Small Business Innovation Research (SBIR) Phase I project titled "A Rapid Nucleic Acid Test for the Point of Care Detection of Malaria." The contract was set aside for total small...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Crosslife Technologies Inc., a for-profit small business, for $299,987.00. The contract is for the development of a point of care nucleic acids test for the detection of the liver flukes Opisthorchis viverrini and Clonorchis. This contract is a Definitive Contract with a Firm Fixed Price pricing type. The...
This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a for-profit manufacturer of biomedical research and genetic analysis tools. The $160,678.75 firm fixed price purchase order is for the delivery of INTELLIFLEX EQUIPMENT with a completion date of August 31, 2022. The contract has no set-aside designation. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation,...
This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention to Life Technologies Corporation, a for-profit provider of laboratory equipment and technologies for biomedical research and genetic analysis. The $118,049.95 firm fixed-price purchase order is for the delivery of unspecified laboratory equipment. The contract has no set-aside designation and was awarded on August 22, 2017, with a completion date of August 29, 2018. As a...
This $221,889 firm fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company, for "Diagnostics to Enable Malaria and Neglected Tropical Diseases". The contract originated from the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS 2018-1, which sought...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Centers for Disease Control and Prevention (CDC) to Microbplex Inc., a minority-owned, economically disadvantaged women-owned small business. The contract has a ceiling value of $987,059.00 and is a Cost Plus Fixed Fee definitive contract. The period of performance runs from September 28, 2015 to September 27, 2017. The contract does not have a set-aside designation. Based on the SBIR program description, this...
This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA to Life Technologies Corporation, a for-profit organization. The $153,549.95 firm fixed-price purchase order is for the delivery of LUMINEX XMAP INTELLIFLEX DRSE products, with a completion date of September 30, 2021. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation, another for-profit manufacturer that has previously...
This is a SBIR Phase I contract award to Cytoimage Inc., a woman-owned small business, by the Centers for Disease Control and Prevention (CDC) of the Department of Health and Human Services (HHS). The award is for $149,531.00 and is a firm fixed price contract. The contract does not have a set-aside designation. The period of performance is from September 12, 2017 to March 11, 2018, with work to be performed in Atlanta, Georgia. The SBIR (Small Business Innovation Research) program is a...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $91,758.84 firm fixed-price purchase order is for the delivery of HIV test kits and supplies. The contract does not have a set-aside designation and has an ultimate completion date of December 31, 2021. Life Technologies Corporation, as the prime contractor, is a leading provider of biomedical research and genetic...